You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

AZOR Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Azor patents expire, and when can generic versions of Azor launch?

Azor is a drug marketed by Cosette and is included in one NDA.

The generic ingredient in AZOR is amlodipine besylate; olmesartan medoxomil. There are fifty drug master file entries for this compound. Eighteen suppliers are listed for this compound. Additional details are available on the amlodipine besylate; olmesartan medoxomil profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for AZOR?
  • What are the global sales for AZOR?
  • What is Average Wholesale Price for AZOR?
Summary for AZOR
US Patents:0
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 3
Raw Ingredient (Bulk) Api Vendors: 42
Drug Prices: Drug price information for AZOR
What excipients (inactive ingredients) are in AZOR?AZOR excipients list
DailyMed Link:AZOR at DailyMed
Drug patent expirations by year for AZOR
Drug Prices for AZOR

See drug prices for AZOR

Drug Sales Revenue Trends for AZOR

See drug sales revenues for AZOR

Paragraph IV (Patent) Challenges for AZOR
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
AZOR Tablets amlodipine besylate; olmesartan medoxomil 10 mg/20 mg and 5 mg/40 mg 022100 1 2008-03-31
AZOR Tablets amlodipine besylate; olmesartan medoxomil 5 mg/20 mg and 10 mg/40 mg 022100 1 2008-02-11

US Patents and Regulatory Information for AZOR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Cosette AZOR amlodipine besylate; olmesartan medoxomil TABLET;ORAL 022100-001 Sep 26, 2007 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cosette AZOR amlodipine besylate; olmesartan medoxomil TABLET;ORAL 022100-004 Sep 26, 2007 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cosette AZOR amlodipine besylate; olmesartan medoxomil TABLET;ORAL 022100-002 Sep 26, 2007 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Cosette AZOR amlodipine besylate; olmesartan medoxomil TABLET;ORAL 022100-003 Sep 26, 2007 AB RX Yes No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for AZOR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Cosette AZOR amlodipine besylate; olmesartan medoxomil TABLET;ORAL 022100-001 Sep 26, 2007 ⤷  Sign Up ⤷  Sign Up
Cosette AZOR amlodipine besylate; olmesartan medoxomil TABLET;ORAL 022100-004 Sep 26, 2007 ⤷  Sign Up ⤷  Sign Up
Cosette AZOR amlodipine besylate; olmesartan medoxomil TABLET;ORAL 022100-003 Sep 26, 2007 ⤷  Sign Up ⤷  Sign Up
Cosette AZOR amlodipine besylate; olmesartan medoxomil TABLET;ORAL 022100-002 Sep 26, 2007 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for AZOR

See the table below for patents covering AZOR around the world.

Country Patent Number Title Estimated Expiration
Ireland 920540 ⤷  Sign Up
European Patent Office 0503785 Dérivés de 1-biphénylimidazole, leur préparation et leur utilisation thérapeutique (1-Biphenylimidazole derivatives, their preparation and their therapeutic use) ⤷  Sign Up
South Korea 0128289 ⤷  Sign Up
Denmark 0573218 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Supplementary Protection Certificates for AZOR

Patent Number Supplementary Protection Certificate SPC Country SPC Expiration SPC Description
0503785 CA 2006 00012 Denmark ⤷  Sign Up
0503785 91056 Luxembourg ⤷  Sign Up 91056, EXPIRES: 20170221
0503785 SPC/GB03/024 United Kingdom ⤷  Sign Up PRODUCT NAME: OLMESARTAN MEDOXOMIL, OPTIONALLY IN THE FORM OF A PHAMACEUTICALLY ACCEPTABLE SALT; REGISTERED: DE 50202.00.00 20020813; DE 50202.01.00 20020813; DE 50202.02.00 20020813; DE 50205.00.00 20020813; DE 50205.01.00 20020813; DE 50205.02.00 20020813; UK PL 08265/0015 20030522; UK PL 08265/0016 20030522; UK PL08265/0017 20030522
0503785 300133 Netherlands ⤷  Sign Up 300133, 20120221, EXPIRES: 20170220
>Patent Number >Supplementary Protection Certificate >SPC Country >SPC Expiration >SPC Description

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.